The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 7079-7086

  Del Rey, Adriana ^a   Roggero, Eduardo ^b   Kabiersch, Alexa ^c   Schäfer, Martin ^d   Besedovsky, Hugo O ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d Institute of Anatomy and Cell Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENERVATION; FEMALE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; LIFESPAN; LYMPHADENOPATHY; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; MOUSE; NONHUMAN; NORADRENERGIC NERVE; ONTOGENY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; SYMPATHECTOMY; SYMPATHETIC INNERVATION;

EID: 33646859993     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.7079     Document Type: Article

References (42)

1. Besedovsky, H. O., and A. del Rey. 1996. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17: 64-102.
2. Heijnen, C. J., and A. Kavelaars. 1999. The importance of being receptive. J. Neuroimmunol. 100: 197-202.
3. Kohm, A. P., and V. M. Sanders. 2000. Norepinephrine: a messenger from the brain to the immune system. Immunol. Today 21: 539-542.
4. Elenkov, I. J., R. L. Wilder, G. P. Chrousos, and E. S. Vizi. 2000. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52: 595-638.
5. Lorton, D., C. Lubahn, and D. Bellinger. 2001. Introduction to biological signaling in Psychoneuroimmunology. In Psychoneuroimmunology, Vol. 1. R. Ader, Felten D., and Cohen, N., eds. Academic, San Diego, pp. 113-160.
6. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16: 39-43.
7. Nose, M., M. Nishihara, J. Kamogawa, M. Terada, and S. Nakatsuru. 2000. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci. Rev Immunogenet. 2: 154-164.
8. del Rey, A., A. Kabiersch, S. Petzoldt, and H. O. Besedovsky. 2002. Involvement of noradrenergic nerves in the activation and clonal deletion of T cells stimulated by superantigen in vivo. J. Neuroimmunol. 127: 44-53.
9. Shirai, A., I. Aoki, M. Otani, J. J. Mond, and D. M. Klinman. 1994. Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice. J. Immunol. 153: 1889-1894.
10. del Rey, A., A. Kabiersch, S. Petzoldt, and H. O. Besedovsky. 2003. Sympathetic abnormalities during autoimmune processes: potential relevance of noradrenaline-induced apoptosis. Ann. NY Acad. Sci. 992: 158-167.
11. Anderson, K. L., G. Anderson, R. H. Michell, E. J. Jenkinson, and J. J. Owen. 1996. Intracellular signaling pathways involved in the induction of apoptosis in immature thymic T lymphocytes. J. Immunol. 156: 4083-4091.
12. Gu, C., Y. C. Ma, J. Benjamin, D. Littman, M. V. Chao, and X. Y. Huang. 2000. Apoptotic signaling through the β-adrenergic receptor. A new Gs effector pathway. J. Biol. Chem. 275: 20726-20733.
13. Besedovsky, H. O., A. del Rey, E. Sorkin, R. Burri, C. G. Honegger, M. Schlumpf, and W. Lichtensteiger. 1987. T lymphocytes affect the development of sympathetic innervation of mouse spleen. Brain Behav. Immun. 1: 185-193.
14. Breneman, S. M., J. A. Moynihan, L. J. Grota, D. L. Felten, and S. Y. Felten. 1993. Splenic norepinephrine is decreased in MRL-lpr/lpr mice. Brain Behav. Immun. 7: 135-143.
15. Kono, D. H., and A. N. Theofilopoulos. 2000. Genetics of systemic autoimmunity in mouse models of lupus. Int. Rev. Immunol. 19: 367-387.
16. del Rey, A., H. O. Besedovsky, E. Sorkin, M. da Prada, and S. Arrenbrecht. 1981. Immunoregulation mediated by the sympathetic nervous system, II. Cell. Immunol. 63: 329-334.
17. Miles, K., S. Atweh, G. Otten, B. G. Arnason, and E. Chelmicka-Schorr. 1984. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice. Int. J. Immunopharmacol. 6: 171-177.
18. Fuchs, B. A., K. S. Campbell, and A. E. Munson. 1988. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 117: 339-351.
19. Kohno, A., B. Cinader, and P. Seeman. 1986. Age-related changes of β-adrenoceptors in spleen lymphocytes and cerebral cortex of NZB/BIN mice. Immunol. Lett. 14: 75-78.
20. Ackerman, K. D., D. L. Bellinger, S. Y. Felten, and D. L. Felten. 1991. Ontogeny and senescence of noradrenergic innervation of the rodent thymus and spleen. In Psychoneuroimmunology, Vol. 1. R. Ader, Felten D., and Cohen, N., eds. Academic, San Diego, pp. 71-125.
21. Felten, S. Y., and J. Olschowka. 1987. Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18: 37-48.
22. Ackerman, K. D., K. S. Madden, S. Livnat, S. Y. Felten, and D. L. Felten. 1991. Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation. Brain Behav. Immun. 5: 235-261.
23. Sanders, V. M., and F. E. Powell-Oliver. 1992. β2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 148: 1822-1828.
24. Besedovsky, H. O., A. del Rey, E. Sorkin, M. Da Prada, and H. H. Keller. 1979. Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 48: 346-355.
25. Kruszewska, B., S. Y. Felten, and J. A. Moynihan. 1995. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J. Immunol. 155: 4613-4620.
26. Jacobson, B. A., T. L. Rothstein, and A. Marshak-Rothstein. 1997. Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice. Immunol. Rev. 156: 103-110.
27. Sanders, V. M., R. A. Baker, D. S. Ramer-Quinn, D. J. Kasprowicz, B. A. Fuchs, and N. E. Street. 1997. Differential expression of the β2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158: 4200-4210.
28. Lechner, O., Y. Hu, M. Jafarian-Tehrani, H. Dietrich, S. Schwarz, M. Herold, F. Haour, and G. Wick. 1996. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10: 337-350.
29. lpr mice. J. Autoimmun. 14: 325-333.
30. +/+ and lpr/lpr mice. Brain Behav Immun. 13: 348-360.
31. Sakic, B., N. Laflamme, L. S. Crnic, H. Szechtman, J. A. Denburg, and S. Rivest. 1999. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. J Neuroimmunol. 96: 80-91.
32. Wilder, R. L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13: 307-338.
33. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17: 138-146.
34. Maini, R. N., M. J. Elliott, P. J. Charles, and M. Feldmann. 1994. Immunological intervention reveals reciprocal roles for tumor necrosis factor-α and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus. Springer Semin. Immunopathol. 16: 327-336.
35. Horwitz, D. A., J. D. Gray, S. C. Behrendsen, M. Kubin, M. Rengaraju, K. Ohtsuka, and G. Trinchieri. 1998. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 41: 838-844.
36. Klein-Schneegans, A. S., L. Kuntz, P. Fonteneau, and F. Loor. 1989. Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL/6 mice and their congenics at the lpr (lymphoproliferation) locus. J. Autoimmun. 2: 869-875.
37. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97: 1597-1604.
38. Jabs, D. A., R. A. Prendergast, E. M. Rorer, A. P. Hudson, and I. A. Whittum-Hudson. 2001. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest. Ophthalmol. Vis. Sci. 42: 2567-2571.
39. Gouet, D., R. Marechaud, P. Aucouturier, G. Touchard, Y. Sudre, and J. L. Preud'homme. 1986. Atenolol induced systemic lupus erythematosus syndrome. J Rheumatol 13: 446-447.
40. Homberg, J. C., N. Abuaf, P. F. Plouin, J. Menard, and J. P. Fillastre. 1983. Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of β-blockers and α-methyldopa. J Pharmacol. 14: 61-66.
41. McGuiness, M., R. A. Frye, and J. S. Deng. 1997. Atenolol-induced lupus erythematosus. J. Am. Acad. Dermatol. 37: 298-299.
42. Wahle, M., U. Stachetzki, A. Krause, M. Pierer, H. Hantzschel, and C. G. Baerwald. 2001. Regulation of β2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro. Cytokine. 16: 205-209.